our team

Adam is the Director of Research at Aquilo Capital Management. He joined Aquilo in January 2010. Prior to joining Aquilo, he served as an Associate at the Biotechology Value Fund, assisting in sourcing and evaluating private and public biotechnology companies. He is a Class 14 Kauffman Fellow and was formerly on the Board of Directors of Airmid and Viriome Inc. Adam was a postdoctoral fellow in Neurobiology at Stanford University’s School of Medicine and has a Ph. D. from Yale University.